Zurcher Kantonalbank (Zurich Cantonalbank) Immunity Bio, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $32.8 Billion
- Q3 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 31,439 shares of IBRX stock, worth $83,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,439
Previous 31,439
-0.0%
Holding current value
$83,313
Previous $116,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IBRX
# of Institutions
205Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$44.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$30.3 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$22.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$10.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$5.95 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.06B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...